The conditions that most commonly support eligibility include: Obesity (BMI 30, or 27 with at least one comorbidity such as hypertension, sleep apnea, or cardiovascular disease) Type 2 diabetes or prediabetes Insulin resistance with clinical documentation Metabolic syndrome (clinically diagnosed) Polycystic Metabolic Ovarian Syndrome (PMOS) and related hormonal disorders Non-alcoholic fatty liver disease (NAFLD/MASLD) Perimenopause-related metabolic dysfunction with documented hormonal changes GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are the most commonly used peptides in metabolic care today
Soluble fiber a type of fiber found in foods like nuts, beans, lentils, and psyllium husk (found in Metamucil) slows digestion to increase satiety, possibly helping you reduce calorie intake
10.1371/journal.pone.0288523 83 JiangR.DuX.LnnerdalB
Schedule A Consultation How to inject semaglutide or tirzepatide properly Using the correct injection technique is essential for ensuring the medication is delivered effectively
In this experiment, researchers induced diabetes in mice by feeding them a high fat diet (HFD) for 16 weeks
Herpetological Review
